{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:04:06Z","timestamp":1787987046127,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002460","name":"Chung-Ang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcin.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:28:36Z","timestamp":1742880516000},"page":"720-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diabetic Status and Thrombogenicity"],"prefix":"10.1016","volume":"18","author":[{"given":"Sungsoo","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonki","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwa","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seok","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-7411","authenticated-orcid":false,"given":"Jin-Sin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Jae","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-3726","authenticated-orcid":false,"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcin.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2337\/diacare.26.10.2947","article-title":"Diabetes and heart disease","volume":"26","author":"Barrett-Connor","year":"2003","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.jcin.2024.12.002_bib2","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2013mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jcin.2024.12.002_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4093\/dmj.2015.39.2.95","article-title":"Current antiplatelet treatment strategy in patients with diabetes mellitus","volume":"39","author":"Jung","year":"2015","journal-title":"Diabetes Metab J"},{"issue":"7","key":"10.1016\/j.jcin.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.109.913376","article-title":"Diabetes and antiplatelet therapy in acute coronary syndrome","volume":"123","author":"Ferreiro","year":"2011","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jcin.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/eurheartj\/ehab128","article-title":"Antithrombotic therapy in diabetes: which, when, and for how long?","volume":"42","author":"Ajjan","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jcin.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-023-01830-7","article-title":"Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type\u00a02 diabetes","volume":"22","author":"Guo","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"10.1016\/j.jcin.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2007.05.049","article-title":"Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease","volume":"50","author":"Angiolillo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jcin.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2019.07.030","article-title":"Impaired spontaneous\/endogenous fibrinolytic status as new cardiovascular risk factor? JACC review topic of the week","volume":"74","author":"Gorog","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jcin.2024.12.002_bib9","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehad088","article-title":"Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jcin.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0039-1701011","article-title":"Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: a PLATO sub-study","volume":"120","author":"Sumaya","year":"2020","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.jcin.2024.12.002_bib11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.jcin.2024.12.002_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.jcin.2024.12.002_bib13","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jcin.2024.12.002_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1160\/TH13-08-0643","article-title":"Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes","volume":"111","author":"Jeong","year":"2014","journal-title":"Thromb Haemost"},{"issue":"24","key":"10.1016\/j.jcin.2024.12.002_bib15","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jcin.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.12.002_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-016-0373-x","article-title":"Flow cytometric analysis of platelets type 2 diabetes mellitus reveals \u201cangry\u201d platelets","volume":"15","author":"Soma","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.jcin.2024.12.002_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.jcin.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev"},{"issue":"9","key":"10.1016\/j.jcin.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1007\/s12325-019-01032-2","article-title":"Association between residual platelet reactivity on clopidogrel treatment and severity of coronary atherosclerosis: intrinsic hypercoagulability as a mediator","volume":"36","author":"Zhao","year":"2019","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jcin.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1160\/TH16-10-0496","article-title":"Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention","volume":"117","author":"Kreutz","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jcin.2024.12.002_bib22","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1055\/s-0038-1645876","article-title":"Prediction of ischemic events after percutaneous coronary intervention: thrombelastography profiles and factor XIIIa activity","volume":"2","author":"Kreutz","year":"2018","journal-title":"TH Open"},{"key":"10.1016\/j.jcin.2024.12.002_bib23","article-title":"Fibrin clot strength in patients with diabetes mellitus measured by thrombelastography","volume":"2018","author":"Maatman","year":"2018","journal-title":"J\u00a0Diabetes Res"},{"issue":"23","key":"10.1016\/j.jcin.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.046448","article-title":"Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jcin.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(01)01555-8","article-title":"Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2024.12.002_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081919","article-title":"Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications","volume":"14","author":"Erem","year":"2005","journal-title":"Med Princ Pract"},{"issue":"suppl_2","key":"10.1016\/j.jcin.2024.12.002_bib28","article-title":"Ischemic and bleeding risk stratification in diabetic patients after acute coronary syndrome based on\u00a0insulin requirement","volume":"41","author":"Cavallari","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jcin.2024.12.002_bib29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11239-017-1473-5","article-title":"Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a \u201creal-world\u201d study","volume":"43","author":"Zhang","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.jcin.2024.12.002_bib30","first-page":"1615","article-title":"Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate","volume":"52","author":"Dinkelaar","year":"2014","journal-title":"Clin Chem Lab Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824018181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824018181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:57:10Z","timestamp":1774324630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824018181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1936879824018181"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2024.12.002","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Status and Thrombogenicity","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}